Medifron DBT Co., Ltd. (KOSDAQ:A065650) agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd. (KOSDAQ:A214270) on April 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,947 KRW | +1.25% |
|
+3.84% | -28.81% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,947 KRW | +1.25% | +3.84% | 47.11M | ||
1,458 KRW | -1.02% | +6.50% | 111M | ||
1st Jan change | Capi. | |
---|---|---|
-28.81% | 47.11M | |
+13.02% | 6.78B | |
-32.02% | 1.45B | |
-14.59% | 1.14B | |
-27.26% | 936M | |
+31.79% | 495M | |
+16.91% | 467M | |
-22.41% | 431M | |
-46.05% | 393M | |
-37.98% | 345M |
- Stock Market
- Equities
- A214270 Stock
- News FSN Co., Ltd.
- Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd..